Genscript Biotech pulls off $304m follow-on

GLOBALCAPITAL INTERNATIONAL LIMITED, a company

incorporated in England and Wales (company number 15236213),

having its registered office at 4 Bouverie Street, London, UK, EC4Y 8AX

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Cookies Settings
Asia

Genscript Biotech pulls off $304m follow-on

Jonathan Breen
June 05, 2018 10:45 am
unilab_Adobe_230x150
Life scientists researching in laboratory. Female young scientist and her post doctoral supervisor microscoping in their working environment. Healthcare and biotechnology. | kasto - stock.adobe.com

Genscript Biotech Corp, a leading life sciences service provider and drug developer, has raised HK$2.39bn ($304m) after upsizing a follow-on offering, according to a source close to the deal.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

JP MorganEquityHong Kong SARAsia Follow-ons and Rights IssuesAsiaGreater ChinaNortheast AsiaAsia PacificABBs-Block TradesFollow-ons and Rights issuesEmerging MarketsSRIGoldman Sachs
JB
Jonathan Breen
Equities editor GlobalCapital Asia
Contact
Gift this article